Eli Lilly and Company and their industry partners, including sample management specialists – Ziath, are speeding the discovery of new medicines through the fully automated Lilly Life Sciences Studio (L2S2) lab in San Diego, USA. L2S2 was set up as part of the Lilly Discovery Automation Research and Technologies Group. The lab has brought together a team of talented automation engineers and scientists in the design, implementation, and operation of a variety of innovative automation projects which are introduced in an informative video...
The life science company Sartorius, through its subgroup Sartorius Stedim Biotech, acquired cell culture specialist Xell AG headquartered in Bielefeld, Germany. Xell AG develops, produces, and markets media and feed supplements for cell cultures, especially for manufacturing viral vectors that are used in gene therapeutics and vaccines....
HORIBA UK announces the first UK installation of its Fluorolog-QM modular research-grade fluorescence spectrometer, the world’s highest-performance fluorescence analyser. The spectrometer will form an integral part of research into novel fluorophores by Dr Marc Etherington of Northumbria University (Newcastle, UK). His team is opening up new scientific understanding of fluorophores in order to offer light-based solutions to real-world issues, including the development of new materials to reduce the energy consumption of household devices....
Nanopharm Ltd., an Aptar Pharma company and leader in contract research and development of orally inhaled and nasally delivered drug products (OINDP) and Leyden Labs, a company targeting commonalities of viral families to protect humanity from known and future viruses, have announced that they have entered into an agreement to develop nasal sprays that may provide broad protection against respiratory viruses...
PharmEnable, an AI drug discovery company unlocking challenging biological targets, announces that it has entered into a drug discovery collaboration with LifeArc, an independent UK medical research charity, to apply their respective technologies and expertise to discover novel oral antiviral drugs with activity against coronaviruses....
At the start of the COVID-19 pandemic in March 2020, Dr Mason and his team set about turning their knowledge of functional genomics to sequencing and understanding the clinical impact of the SARS-CoV-2 virus. The lab developed multiple methods to detect infections, track strain evolution, and identify biomarkers of disease course to assist with clinical identification and treatment....
MolGen B.V., a single-source supplier of DNA/RNA extraction technology and services for the life sciences and biotechnology, announce its entrance into the U.S. market with the launch of MolGen USA, a joint venture with California-based, laboratory automation experts Todaro Robotics. MolGen USA will operate a complete commercial team and product showroom at the San Diego facility....
Agilent Technologies Inc., has announced the availability of an optimized and verified eMethod for PFAS Analysis in Water by LC/TQ for testing per- and polyfluoroalkyl substances (PFAS) in drinking and surface water using liquid chromatography and mass spectrometry. PFAS—known as ‘Forever Chemicals’—are a group of man-made chemicals that include PFOA, PFOS, GenX, and many others....
The Alliance’s newly published heuristics address these challenges by guiding designers on critical elements of the design and data lifecycle, and to embed known data standards, including the FAIR principles (findable, accessible, interoperable, and reusable). The heuristics are the result of a collaboration between two Pistoia Alliance projects, UXLS and FAIR communities, from PerkinElmer....
PerkinElmer announce it has entered into an agreement to acquire BioLegend, a leading, global provider of life science antibodies and reagents, for approximately $5.25 billion in a combination of cash and stock, subject to certain adjustments. BioLegend provides its academic and biopharmaceutical customers with best-in-class antibodies and reagents in high-growth areas such as cytometry...
Researchers at Queen's University Belfast are using microfluidics to fabricate particles for the encapsulation of drugs and biologics for imaging, treatment and cell targeting. Dr Dimitrios Lamprou, a Reader in Pharmaceutical Engineering at the School of Pharmacy, explained: “Our work involves the microfluidic preparation of lipid (liposome) and polymer-based (PLGA) nanoparticles that can efficiently encapsulate cancer drugs...
Every day, regulatory, clinical, quality, and marketing teams at diagnostics manufacturers must refer to the EU’s upcoming In Vitro Diagnostic Regulation (IVDR). In order to make this process easier, a new, freely available IVDR filtering tool is being offered to the market by RQM+, the world's leading medical device and diagnostics focused regulatory and quality consulting firm...
Severe COVID-19 and Rheumatoid Arthritis (RA) share some common pathogenic mechanisms, according to a new study. The observations from the study – published in JCI Insight and led by the University of Glasgow’s Research into Inflammatory Arthritis Centre (RACE) in collaboration with the Fondazione A.Gemelli IRCCS in Italy –could help development of new treatment strategies for severe COVID-19...
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has announced the acquisition of iGenomX, a company offering multiplex library preparation tools for next-generation sequencing (NGS) workflows. The acquisition is expected to enhance Twist’s capabilities to support multiplex sequencing preparations across multiple markets...
Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (High Performance IMS) and Compact Ion Mobility Mass Spectrometry (MS), signals its commitment to the pharmaceutical industry with the introduction of GMP-compliant at-line PAT (process analytical technology) and an increasing body of literature demonstrating its value in pharmaceutical applications...
Cutting-edge SP i-Dositecno robotic filling and capping equipment to be installed in NIBRT’s global center of excellence for bioprocessing training and research. SP Scientific Products (SP) announces a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT) in Dublin, Ireland, to install a modular multi-container filling line and isolation system...
Aptamer Group, the developer of Optimer™ therapeutics and diagnostics, has secured a contract with a top five global pharmaceutical company to develop Optimers to support the development of a novel vaccine candidate for neurodegenerative disease. The agreement includes an initial upfront payment to Aptamer Group with long term recurring licensing fees for over 10 years...
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies technologies...
In the pharmaceutical industry, the trend is to move from conventional batch manufacturing to continuous manufacturing processes. The challenges for such change are numerous, but many papers are published to solve those issues and improve production. This is the case of the paper published by Carl Allenspach from Bristol-Myers Squibb (International Journal of Pharmaceutics 596 (2021)....
Owlstone Medical (or the “Company”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs (NPS)...
Merck, a leading science and technology company, has announced the winners of this year’s Future Insight Prize. The € 1 million prize in the category of “Food Generation” was awarded during the Future Insight Days in Darmstadt, Germany, to Ting Lu, Professor of Bioengineering at the University of Illinois Urbana-Champaign, USA, and Stephen Techtmann, Associate Professor of Biological Sciences at Michigan Technological University, USA....
ZEISS are thrilled to announce the ZEISS Microscopy Image Contest 2021. Do you take stunning microscopy images? Submit your best image now! The contest is open to all microscopy enthusiasts and professionals in any application field. Images can be taken with any ZEISS microscope (light, X-ray or electron microscope). Deadline for entry is Saturday 31st July, 2021...
Eli Lilly and Company and their industry partners, including sample management specialists – Ziath, are speeding the discovery of new medicines through the fully automated Lilly Life Sciences Studio (L2S2) lab in San Diego, USA. L2S2 was set up as part of the Lilly Discovery Automation Research and Technologies Group. The lab has brought together a team of talented automation engineers and scientists in the design, implementation, and operation of a variety of innovative automation projects which are introduced in an informative video...
The life science company Sartorius, through its subgroup Sartorius Stedim Biotech, acquired cell culture specialist Xell AG headquartered in Bielefeld, Germany. Xell AG develops, produces, and markets media and feed supplements for cell cultures, especially for manufacturing viral vectors that are used in gene therapeutics and vaccines....
HORIBA UK announces the first UK installation of its Fluorolog-QM modular research-grade fluorescence spectrometer, the world’s highest-performance fluorescence analyser. The spectrometer will form an integral part of research into novel fluorophores by Dr Marc Etherington of Northumbria University (Newcastle, UK). His team is opening up new scientific understanding of fluorophores in order to offer light-based solutions to real-world issues, including the development of new materials to reduce the energy consumption of household devices....
Nanopharm Ltd., an Aptar Pharma company and leader in contract research and development of orally inhaled and nasally delivered drug products (OINDP) and Leyden Labs, a company targeting commonalities of viral families to protect humanity from known and future viruses, have announced that they have entered into an agreement to develop nasal sprays that may provide broad protection against respiratory viruses...
PharmEnable, an AI drug discovery company unlocking challenging biological targets, announces that it has entered into a drug discovery collaboration with LifeArc, an independent UK medical research charity, to apply their respective technologies and expertise to discover novel oral antiviral drugs with activity against coronaviruses....
At the start of the COVID-19 pandemic in March 2020, Dr Mason and his team set about turning their knowledge of functional genomics to sequencing and understanding the clinical impact of the SARS-CoV-2 virus. The lab developed multiple methods to detect infections, track strain evolution, and identify biomarkers of disease course to assist with clinical identification and treatment....
MolGen B.V., a single-source supplier of DNA/RNA extraction technology and services for the life sciences and biotechnology, announce its entrance into the U.S. market with the launch of MolGen USA, a joint venture with California-based, laboratory automation experts Todaro Robotics. MolGen USA will operate a complete commercial team and product showroom at the San Diego facility....
Agilent Technologies Inc., has announced the availability of an optimized and verified eMethod for PFAS Analysis in Water by LC/TQ for testing per- and polyfluoroalkyl substances (PFAS) in drinking and surface water using liquid chromatography and mass spectrometry. PFAS—known as ‘Forever Chemicals’—are a group of man-made chemicals that include PFOA, PFOS, GenX, and many others....
The Alliance’s newly published heuristics address these challenges by guiding designers on critical elements of the design and data lifecycle, and to embed known data standards, including the FAIR principles (findable, accessible, interoperable, and reusable). The heuristics are the result of a collaboration between two Pistoia Alliance projects, UXLS and FAIR communities, from PerkinElmer....
PerkinElmer announce it has entered into an agreement to acquire BioLegend, a leading, global provider of life science antibodies and reagents, for approximately $5.25 billion in a combination of cash and stock, subject to certain adjustments. BioLegend provides its academic and biopharmaceutical customers with best-in-class antibodies and reagents in high-growth areas such as cytometry...
Researchers at Queen's University Belfast are using microfluidics to fabricate particles for the encapsulation of drugs and biologics for imaging, treatment and cell targeting. Dr Dimitrios Lamprou, a Reader in Pharmaceutical Engineering at the School of Pharmacy, explained: “Our work involves the microfluidic preparation of lipid (liposome) and polymer-based (PLGA) nanoparticles that can efficiently encapsulate cancer drugs...
Every day, regulatory, clinical, quality, and marketing teams at diagnostics manufacturers must refer to the EU’s upcoming In Vitro Diagnostic Regulation (IVDR). In order to make this process easier, a new, freely available IVDR filtering tool is being offered to the market by RQM+, the world's leading medical device and diagnostics focused regulatory and quality consulting firm...
Severe COVID-19 and Rheumatoid Arthritis (RA) share some common pathogenic mechanisms, according to a new study. The observations from the study – published in JCI Insight and led by the University of Glasgow’s Research into Inflammatory Arthritis Centre (RACE) in collaboration with the Fondazione A.Gemelli IRCCS in Italy –could help development of new treatment strategies for severe COVID-19...
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has announced the acquisition of iGenomX, a company offering multiplex library preparation tools for next-generation sequencing (NGS) workflows. The acquisition is expected to enhance Twist’s capabilities to support multiplex sequencing preparations across multiple markets...
Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (High Performance IMS) and Compact Ion Mobility Mass Spectrometry (MS), signals its commitment to the pharmaceutical industry with the introduction of GMP-compliant at-line PAT (process analytical technology) and an increasing body of literature demonstrating its value in pharmaceutical applications...
Cutting-edge SP i-Dositecno robotic filling and capping equipment to be installed in NIBRT’s global center of excellence for bioprocessing training and research. SP Scientific Products (SP) announces a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT) in Dublin, Ireland, to install a modular multi-container filling line and isolation system...
Aptamer Group, the developer of Optimer™ therapeutics and diagnostics, has secured a contract with a top five global pharmaceutical company to develop Optimers to support the development of a novel vaccine candidate for neurodegenerative disease. The agreement includes an initial upfront payment to Aptamer Group with long term recurring licensing fees for over 10 years...
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies technologies...
In the pharmaceutical industry, the trend is to move from conventional batch manufacturing to continuous manufacturing processes. The challenges for such change are numerous, but many papers are published to solve those issues and improve production. This is the case of the paper published by Carl Allenspach from Bristol-Myers Squibb (International Journal of Pharmaceutics 596 (2021)....
Owlstone Medical (or the “Company”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has announced the publication of a peer-reviewed study in Nature Scientific Reports. The paper investigates the performance of filters embedded in face masks for supporting the detection of SARS-CoV-2 as an alternative to nasopharyngeal swabs (NPS)...
Merck, a leading science and technology company, has announced the winners of this year’s Future Insight Prize. The € 1 million prize in the category of “Food Generation” was awarded during the Future Insight Days in Darmstadt, Germany, to Ting Lu, Professor of Bioengineering at the University of Illinois Urbana-Champaign, USA, and Stephen Techtmann, Associate Professor of Biological Sciences at Michigan Technological University, USA....
ZEISS are thrilled to announce the ZEISS Microscopy Image Contest 2021. Do you take stunning microscopy images? Submit your best image now! The contest is open to all microscopy enthusiasts and professionals in any application field. Images can be taken with any ZEISS microscope (light, X-ray or electron microscope). Deadline for entry is Saturday 31st July, 2021...